ArticleActa Cardiologica Sinica2013

Effect of 8-Week Combination Therapy with an Extended-Release α1-Blocker (Bunazosin or Doxazosin) in Inadequate Responders to an Angiotensin II Antagonist (Valsartan) in Patients with Stage 1 or 2 Essential Hypertension.

Shao-Chi Yang et al.PubMed ↗Full text ↗

No numbers read from the abstract.